Safe vaccines for Europeans - #StrongerTogether  
The European Commission has secured up to 4.6 billion doses of COVID-19 vaccines so far and negotiations are underway for additional doses. Vaccine deliveries to EU countries have increased steadily and vaccination is gathering pace. The Commission is also working with industry to step up vaccine manufacturing capacity. 

Vaccine data December 2021

The EU has reached a crucial milestone with 70% of the adult population now fully vaccinated against COVID-19. In total, over 256 million adults in the EU have now received a full vaccine course. The Commission and EU countries have pledged close to €3 billion to COVAX, the global initiative aimed at ensuring equitable access to COVID-19 vaccines, and are supporting vaccination campaigns in partner countries. More information are available here​

For latest communications on the EU coronavirus vaccines strategy please visit this web​page.​

For data on vaccination progress in Europe, visit the ECDC's COVID-19 Vaccine Tracker, or the WHO COVID​-19 Vaccine Programme Monitor (Europe).​

​ A new Flash Eurobarometer survey conducted at the end of May 2021 showed that 75% agree that COVID-19 vaccines are the only way to end the pandemic. 69% are either already vaccinated, or eager to be vaccinated as soon as possible, although there are significant variations among Member States and by age group. Read more.


1. Securing future COVID-19 vaccines for Europeans
2. How do COVID-19 vaccines work?
3. The health benefits of vaccination
4. COVID-19 vaccines: How are they developed, authorised and put on the market?
5. COVID-19 vaccines: Making sure they are safe
6. Vaccines and vaccination: the way out of the coronavirus pandemic – Next steps
7. Preparing Europe for COVID-19 variants


1. Safe vaccine for Europeans - subtitles in all languages
2. How many vaccines the EU has secured, who is going to get them and when?
3. How are vaccines approved in the EU
4. Covid-19 vaccinations: more solidarity and transparency needed (Europarl TV)
5. Covid-19 vaccine: why so fast (Council of the EU)

More videos are available on the Audiovisual Service webpage of the European Commission.

Other resources

1. European Commission: Safe COVID-19 vaccines for Europeans
2. European Commission: Coronavirus response
4. European Commission: Toolkit for health professionals
5. European Parliament: Vaccines against Covid-19
7. EMA recommends first (BioNTech/Pfizer) COVID-19 vaccine for authorisation in the EU (21 December 2021)
8. EMA recommends second (Moderna) COVID-19 Vaccine for authorisation in the EU (6 January 2021)
9. EMA r​ecommends third (AstraZeneca)​ COVID-19 Vaccine for authorisation in the EU​​​ (29 January 2021)​
1​0. EM​​A recommends fourth (Johnson&Johnson) COVID-19 Vaccine for authorisation in the EU (11 March 2021)​
​11. EMA approves first COVID-19 Vaccine for children aged 12-15 (28 May 2021) 
12. EMA approves Moderna vaccine for children aged 12-17 (23 July 2021)
13. EMA recommends approval of Pfizer COVID-19 vaccine for children aged 5-11 (25 November 2021)
14. EMA recommends fifth (Novavax) COVID-19 Vaccine​ for authorization in the EU (20 December 2021)​

Susijusi informacija